Skip to main content
Year archive

SHIELD THERAPEUTICS PLC — 2024 filings

All 20 regulatory filings released by SHIELD THERAPEUTICS PLC (STX) in 2024, sourced directly from the official regulator.

20 Filings
2024 Period
2024 filings (20)
Filing Released Lang
Result of General Meeting & Total Voting Rights
AGM Information
2024-12-24 English
Results of RetailBook Offer
Share Issue/Capital Change
2024-12-23 English
RetailBook Offer
Capital/Financing Update
2024-12-06 English
Subscription by AOP Health to raise US$10 million
Regulatory Filings
2024-12-06 English
Business Update
Regulatory Filings
2024-11-21 English
Q3 Trading Update
Earnings Release Q3 2024
2024-10-29 English
Results from Phase 3 paediatric study
Regulatory Filings
2024-09-25 English
Interim results
Earnings Release H1 2024
2024-09-04 English
ACCRUFeR® Approved by Health Canada
Regulatory Filings
2024-08-27 English
Notice of interim results
Report Publication Announcement
2024-08-14 English
Unaudited Q2 2024 Trading Update
Earnings Release Q2 2024
2024-07-24 English
Directorate Change
Board/Management Information
2024-07-24 English
$5.7m Milestone Monetization Agreement with AOP
Regulatory Filings
2024-07-03 English
Results of 2024 Annual General Meeting
AGM Information
2024-06-20 English
New Drug Application for Accrufer® in South Korea
Regulatory Filings
2024-05-28 English
Audited results for the year ended 31 Dec 2023
Report Publication Announcement FY 2023
2024-05-10 English
Business Update for Q1 2024
Earnings Release Q1 2024
2024-04-30 English
Notice of Results
Report Publication Announcement
2024-04-16 English
Unaudited Full Year Trading Update
Earnings Release FY 2023
2024-02-21 English
Appointment of new Chief Financial Officer
Board/Management Information
2024-01-09 English